1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Oftalmología

Oftalmología

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Hernández-Jiménez E, Del Campo R, Toledano V, Vallejo-Cremades MT, Muñoz A, Largo C, Arnalich F, García-Rio F, Cubillos-Zapata C, López-Collazo E.

    Biofilm vs. planktonic bacterial mode of growth: Which do human macrophages prefer?

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS . 441(4): 947-952. Nº de citas: 30

    [doi:10.1016/j.bbrc.2013.11.012]

  • Arnalich-Montiel F, Hernández-Verdejo JL, Oblanca N, Muñoz-Negrete FJ, De Miguel MP.

    Comparison of corneal haze and visual outcome in primary DSAEK versus DSAEK following failed DMEK

    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY . 251(11): 2575-2584. Nº de citas: 29

    [doi:10.1007/s00417-013-2460-y]

  • Noval S, Visa J, Contreras I.

    Visual field defects due to optic disk drusen in children

    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY . 251(10): 2445-2450. Nº de citas: 23

    [doi:10.1007/s00417-013-2384-6]

  • Martín-Navarro CM, López-Arencibia A, Arnalich-Montiel F, Valladares B, Piñero JE, Lorenzo-Morales J.

    Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba

    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY . 251(9): 2111-2117. Nº de citas: 30

    [doi:10.1007/s00417-013-2371-y]

  • Sala-Puigdollers A, Fernández I, Coco RM, Sanabria MR, Rodríguez de la Rúa E, Ruiz-Moreno JM, Navea A, Suárez de Figueroa M, Pastor JC.

    External validation of existing formulas to predict the risk of developing proliferative vitreoretinopathy: the Retina 1 Project; report 5.

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES . 33(8): 1519-1527. Nº de citas: 7

    [doi:10.1097/IAE.0b013e31828991ea]

  • Holz FG, Bandello F, Gillies M, Mitchell P, Osborne A, Sheidow T, Souied E, Figueroa MS.

    Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme

    BRITISH JOURNAL OF OPHTHALMOLOGY . 97(9): 1161-1167. Nº de citas: 75

    [doi:10.1136/bjophthalmol-2013-303232]

  • Noval S, Oreja-Guevara C, Contreras I.

    Monitoring neuromyelitis optica activity

    EXPERT REVIEW OF NEUROTHERAPEUTICS . 13(9): 989-999.

    [doi:10.1586/14737175.2013.832850]

  • Arnalich-Montiel F, Lorenzo-Morales J, Irigoyen C, Morcillo-Laiz R, López-Vélez R, Muñoz-Negrete F, Piñero JE, Valladares B.

    Co-isolation of Vahlkampfia and Acanthamoeba in Acanthamoeba-Like Keratitis in a Spanish Population

    Cornea . 32(5): 608-614. Nº de citas: 12

    [doi:10.1097/ICO.0b013e31825697e6]

  • Figueroa MS, Contreras I, Noval S.

    Anatomic and visual outcomes of 23-G vitrectomy without scleral buckling for primary rhegmatogenous retinal detachment

    EUROPEAN JOURNAL OF OPHTHALMOLOGY . 23(3): 417-422. Nº de citas: 12

    [doi:10.5301/ejo.5000234]

  • Rebolleda G, González-López JJ, Muñoz-Negrete FJ, Oblanca N, Costa-Frossard L, Álvarez-Cermeño JC.

    Color-Code Agreement Among Stratus, Cirrus, and Spectralis Optical Coherence Tomography in Relapsing-Remitting Multiple Sclerosis With and Without Prior Optic Neuritis

    AMERICAN JOURNAL OF OPHTHALMOLOGY . 155(5): 890-897. Nº de citas: 22

    [doi:10.1016/j.ajo.2012.11.025]

  • Lorenzo-Morales J, Martín-Navarro CM, López-Arencibia A, Arnalich-Montiel F, Piñero JE, Valladares B.

    Acanthamoeba keratitis: an emerging disease gathering importance worldwide?

    TRENDS IN PARASITOLOGY . 29(4): 181-187. Nº de citas: 171

    [doi:10.1016/j.pt.2013.01.006]

  • Muñoz Noval A, García R, Ruiz Casas D, Losada Bayo D, Sánchez Vaquero V, Torres Costa V, Martín Palma RJ, García MA, García Ruiz JP, Serrano Olmedo JJ, Muñoz Negrete JF, del Pozo Guerrero F, Manso Silván M.

    Design and characterization of biofunctional magnetic porous silicon flakes

    ACTA BIOMATERIALIA . 9(4): 6169-6176. Nº de citas: 8

    [doi:10.1016/j.actbio.2012.12.008]

  • González-López JJ, Morcillo-Laiz R, Muñoz-Negrete FJ.

    Adenoviral keratoconjunctivitis: an update.

    Archivos de la Sociedad Espanola de Oftalmologia . 88(3): 108-115.

    [doi:10.1016/j.oftal.2012.07.007]

  • García-De-Vicuña C, Díaz-Llopis M, Salom D, Bou R, Díaz-Cascajosa J, Cordero-Coma M, Ortega G, Ortego-Centeno N, Suarez-De-Figueroa M, Cruz-Martínez J, Fonollosa A, Blanco R, García-Aparicio ÁM, Benítez-Del-Castillo JM, Antón J.

    Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis

    MEDIATORS OF INFLAMMATION . 2013: 560632-560632. Nº de citas: 36

    [doi:10.1155/2013/560632]

  • Rebolleda G, Pérez-López M, Casas-LLera P, Contreras I, Muñoz-Negrete FJ.

    Visual and anatomical outcomes of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids

    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY . 251(1): 255-260. Nº de citas: 44

    [doi:10.1007/s00417-012-1995-7]

  • García-Arumí J, Martínez-Castillo V, Boixadera A, Blasco H, Marticorena J, Zapata MÁ, Macià C, Badal J, Distéfano L, Rafart JM, Berrocal M, Zambrano A, Ruíz-Moreno JM, Figueroa MS.

    Rhegmatogenous retinal detachment treatment guidelines.

    Archivos de la Sociedad Espanola de Oftalmologia . 88(1): 11-35.

    [doi:10.1016/j.oftal.2011.10.013]

  • Figueroa MS, Contreras I.

    Potential Anti-Vascular Endothelial Growth Factor Therapies for Central Retinal Vein Occlusion

    Drugs . 72(16): 2063-2071. Nº de citas: 4

    [doi:10.2165/11640820-000000000-00000]

  • Arnalich-Montiel F, Almendral A, Arnalich F, Valladares B, Lorenzo-Morales J.

    Mixed Acanthamoeba and multidrug-resistant Achromobacter xyloxidans in late-onset keratitis after laser in situ keratomileusis

    JOURNAL OF CATARACT AND REFRACTIVE SURGERY . 38(10): 1853-1856. Nº de citas: 18

    [doi:10.1016/j.jcrs.2012.08.022]